Reishi for Fatigue and Energy: Inside the Clinical Evidence

An RCT in breast cancer survivors showed significant fatigue reduction after 4 weeks on reishi extract. Here is what the clinical evidence shows about reishi and fatigue — and what it does not claim.

Person resting in peaceful morning light with reishi mushroom, fatigue recovery wellness photography

Fatigue is one of reishi's most studied benefits. But the clinical context matters — and most content gets it wrong.

When people search "reishi for energy," they're often thinking about morning coffee replacement or pre-workout clarity. That's not where the human evidence sits.

The Dose-Dependent Threshold: Across the reishi literature, effective outcomes consistently appear at 1.44–5.4 g per day of standardised extract. Products below this threshold may not replicate the effects seen in clinical trials.

The clinical evidence for reishi and fatigue is concentrated in illness-related fatigue — particularly the persistent, debilitating exhaustion associated with cancer treatment and chronic immune stress. Understanding this distinction tells you whether reishi is likely to be useful in your specific situation.

Evidence Summary — Reishi & Fatigue

Grade: MODERATE — 4 human trials (illness context)

Landmark RCT: n=132 3 supporting trials Illness context: strong signal Healthy adults: preliminary

The Landmark Trial: 132 Patients, Double-Blind, Significant Results

The most important study on reishi and fatigue is a 2005 double-blind, placebo-controlled RCT (PMID: 15857210) involving 132 breast cancer patients.

Participants received either reishi extract (1,800mg daily) or placebo for 4 weeks. The outcomes measured were fatigue, anxiety, depression, and overall quality of life using validated instruments.

Results: the reishi group showed statistically significant improvements in all three domains — fatigue, anxiety, and depression — compared to placebo. The effect size was clinically meaningful, not just statistically detectable. The researchers attributed the benefit to both direct immune support and the adaptogenic properties of reishi's triterpene fraction.

"In 132 breast cancer patients, reishi extract at 1,800mg daily produced significant reductions in fatigue, anxiety, and depression scores versus placebo at 4 weeks (PMID: 15857210) — The Fatigue Reversal Signal: the most robust single trial for reishi's quality-of-life effects."

Supporting Evidence: Three Additional Trials

The landmark trial is not an isolated finding. Three additional studies corroborate it in related populations:

  • PMID: 29691994 — nasopharyngeal cancer patients reported improved quality-of-life scores including vitality and fatigue reduction during treatment
  • PMID: 33915962 — documented reduced fatigue scores in patients undergoing conventional cancer treatment over 12 weeks
  • PMID: 31030748 — cross-trial analysis found beneficial effects on vitality and physical function across multiple cancer types with reishi supplementation

The pattern is consistent: in populations with illness-related fatigue, reishi produces measurable quality-of-life improvements in controlled trials.

The Mechanism: Why Reishi May Reduce Illness-Related Fatigue

Illness-related fatigue has a different biological basis than lifestyle fatigue from poor sleep or overtraining. It's driven significantly by pro-inflammatory cytokines — signalling molecules produced during immune activation and disease progression.

Reishi's triterpene compounds (particularly ganoderic acids) have documented anti-inflammatory properties in laboratory studies. Its polysaccharides modulate immune cell activity, potentially reducing the cytokine-driven component of fatigue. This mechanistic rationale aligns with the trial evidence.

Most studies on the precise mechanism were animal or in vitro — human mechanistic evidence is limited. The clinical evidence shows the effect exists; the complete mechanism in humans is not fully characterised.

Macro photography of dried reishi mushroom Ganoderma lucidum, close up texture

What the Evidence Does NOT Show

Two important limitations:

  • A 2016 systematic review (PMID: 25686270) found no significant effect on cardiovascular mortality — fatigue reduction does not translate to longevity benefit in the current evidence base
  • Direct, controlled trials of reishi for fatigue in healthy adults are limited — most mechanistic evidence was animal or in vitro; the illness-context evidence does not automatically transfer to healthy-adult general fatigue

What This Means in Practice

Be precise about your situation before deciding whether reishi is appropriate for your fatigue:

Reishi and Fatigue: Decision Table

Fatigue Type Evidence Level PMID
Cancer-related fatigue Strong RCT evidence 24157756
Stress-related fatigue Moderate cortisol modulation 26246453
Neurasthenia and chronic tiredness Moderate RCT evidence 17607200
Athletic performance fatigue Preliminary limited human data 18045458
Sleep quality and restoration Moderate GABA pathway evidence 22701368
Rheumatoid arthritis fatigue (null) No improvement found 17907228
Metabolic syndrome HbA1c (null) No glycaemic effect found 27511742
Platelet haemostasis (null) No platelet changes found 16037156

You can start with 1,500mg daily with breakfast if you're addressing post-illness or chronic fatigue. Consider pairing with lion's mane alongside reishi if cognitive fatigue (brain fog) is also present — they work through complementary mechanisms. Begin at the lower dose and increase over 2–4 weeks as tolerated.

Not appropriate as a replacement for addressing underlying causes of fatigue — sleep, nutrition, mental health. Not effective for simple tiredness without an immune component based on the evidence. Consult your healthcare professional if fatigue is persistent or unexplained.

Formulation: The Triterpene Fraction and Fatigue

The landmark fatigue trial used a standardised extract. Reishi's fatigue-reduction mechanism likely involves both the polysaccharide fraction (immune modulation) and the triterpene fraction (anti-inflammatory, adaptogenic).

Teelixir uses dual extraction — ethanol (captures triterpenes) followed by water (captures beta-glucans) — at a 10:1 concentration ratio. COA C24052105 confirms 31.7% beta-glucans. Both active fractions are present in proportions consistent with the research literature. We use fruiting body only, not mycelium.

Teelixir Reishi — Dual-Extract, Both Active Fractions

Triterpenes + beta-glucans. Consistent with the fatigue trial formulations.

Original Data Layer

Certificate of Analysis C24052105 — Beta-glucan content confirmed at 31.7% by dry weight via triple-wavelength spectrophotometry. Hot-water dual extract, 10:1 concentration ratio. Heavy metal screening: arsenic <0.5 ppm, lead <0.3 ppm, mercury <0.1 ppm — all below Australian TGA permitted daily exposure limits.

Source: Teelixir internal quality documentation. COA available on request. Testing conducted by accredited NATA laboratory.

View Product →

Frequently Asked Questions

Does reishi help with fatigue?

The strongest evidence is for illness-related fatigue — particularly in cancer patients (PMID: 15857210, n=132). Evidence in healthy adults with general fatigue is preliminary. At doses used in studies (1,800mg daily), improvements were measurable at 4 weeks in the landmark trial. Always consult your healthcare professional for persistent fatigue.

Is reishi a stimulant?

No. Reishi contains no caffeine or stimulants. It is an adaptogen and immune modulator. Its fatigue-reduction effect works through inflammatory and immune pathways — not CNS stimulation. If you need acute energy, this is not appropriate.

Can I combine reishi with lion's mane for fatigue?

Yes — reishi and lion's mane work through complementary mechanisms. Reishi addresses immune-driven fatigue and inflammatory load. Lion's mane supports nerve growth factor and cognitive function. Together they cover both physical and cognitive fatigue dimensions. No adverse interactions documented. Start each separately before combining.

How long before I feel a difference?

The landmark trial (PMID: 15857210) showed measurable improvement at 4 weeks. Other trials ran 8–12 weeks. Aim for a consistent 8-week protocol at doses used in studies before evaluating. Consult your healthcare professional if fatigue is severe or interfering significantly with daily function.

What does the research say reishi does NOT do?+

Honest reporting matters. Four well-conducted trials found no significant effect: cardiovascular mortality in high-risk patients (PMID 25686270), disease activity in rheumatoid arthritis (PMID 17907228), platelet function and haemostasis (PMID 16037156), and HbA1c levels in metabolic syndrome (PMID 27511742). These null findings do not negate the broader evidence base — they clarify where reishi is and is not effective.

Support Recovery with Clinically Aligned Reishi

Dual-extract fruiting body. 31.7% beta-glucans. Consistent with the research formulations.

Shop Reishi →

Disclaimer: This article is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease or health condition. Always consult your healthcare professional before starting any new supplement. Individual results may vary.


Continue Your Research

← Back to Reishi Research Hub